Crossmark

Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function

Crossref DOI link: https://doi.org/10.1186/s12967-019-2004-2

Published Online: 2019-08-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ulbar, Francesca

Montemurro, Tiziana

Jofra, Tatiana

Capri, Miriam

Comai, Giorgia

Bertuzzo, Valentina

Lavazza, Cristiana

Mandelli, Alessandra

Viganò, Mariele

Budelli, Silvia

Bacalini, Maria Giulia

Pirazzini, Chiara

Garagnani, Paolo

Giudice, Valeria

Sollazzo, Daria

Curti, Antonio

Arpinati, Mario

La Manna, Gaetano

Cescon, Matteo

Pinna, Antonio Daniele

Franceschi, Claudio

Battaglia, Manuela

Giordano, Rosaria

Catani, Lucia https://orcid.org/0000-0002-4650-201X
Lemoli, Roberto Massimo
Funding

Funding for this research was provided by:

Italian Ministry of Health (RF-2011-02346763)
License Information

Text and Data Mining valid from 2019-08-05

Version of Record valid from 2019-08-05
More Information

Article History

Received: 19 March 2019

Accepted: 27 July 2019

First Online: 5 August 2019

Ethics approval and consent to participate

: Patients/controls provided written informed consent and the study was approved approved by the local ethical Committee (232/2015/O/Tess by Investigation Drug Service, Azienda Ospedaliero-Universitaria di Bologna).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below